Product Information
RIVASTIGMINE 3 MG CAPSULE is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.1494 per EA under NDC 33342009009. Its NADAC has been published 585 times since Jun 10, 2015.
FDA first approved this application on Aug 22, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342009009
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RIVASTIGMINE TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA203148FDA Approved
8/22/2014
TE Code
AB
On Market Since
9/2/2014
Pharmacological Classes
Price Statistics
The NADAC for RIVASTIGMINE 3 MG CAPSULE has been published 585 times since Jun 10, 2015, and over the history we have for it it has declined 90.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1494 per EA |
|---|---|
| All-time high | $1.6656 (Aug 12, 2015) |
| All-time low | $0.1451 (Jul 17, 2024) |
| 52-week high | $0.2016 |
| 52-week low | $0.1494 |
| Median price | $0.3261 |
| Average price | $0.4810 |
| Largest weekly change | -37.0% (Sep 20, 2017) |
| Weeks tracked | 585 |
| Tracking since | Jun 10, 2015 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RIVASTIGMINE 3 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RIVASTIGMINE 3 MG CAPSULE, manufactured by Macleods Pharmaceuticals Limited, is $0.1494 per EA (NDC 33342009009), effective Aug 19, 2026.
How has the price of RIVASTIGMINE 3 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RIVASTIGMINE 3 MG CAPSULE has declined 90.4%. It has been tracked across 585 weekly CMS publications since Jun 10, 2015.
What are the highest and lowest recorded NADAC prices for RIVASTIGMINE 3 MG CAPSULE?
Since Jun 10, 2015, the NADAC for RIVASTIGMINE 3 MG CAPSULE has ranged from a low of $0.1451 (Jul 17, 2024) to a high of $1.6656 (Aug 12, 2015), with a median of $0.3261 per EA.
Are there cheaper alternatives to RIVASTIGMINE 3 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RIVASTIGMINE 3 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures RIVASTIGMINE 3 MG CAPSULE?
RIVASTIGMINE 3 MG CAPSULE (NDC 33342009009) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.